Philips

Noninvasix, Inc. (the “Company” or “Noninvasix”) is a medical technology company that has developed a novel solution to non-invasively monitor for the first time, oxygen sufficiency in organs and veins. The Company was founded in 2007 by Dr. Donald Prough and Dr. Rinat Esenaliev at the University of Texas Medical Branch (UTMB) and is based out of Houston, Texas. The Company has raised over $6.8 million to date including a seed round in Q4 2021. The platform technology of the Company has been developed with $6 million in grants from the NIH and DOD. The Company has also been a part of prestigious accelerator programs such as Philips Healthworks, TMCx, JLabs, Health Wildcatters and has won multiple awards for their innovation. The non-invasive technology has been clinically validated in multiple peer-reviewed journals. The IP portfolio of the Company includes 9 U.S. and 8 global patents.

Medumo is a healthcare statrtup that helps healthcare organizations deliver the right instructions to the right patients at the right time using automated SMS and email. The company combines technologies in mobile communication and artificial intelligence to equip providers with the capability to engage their patients more without more time or money. It also empowers patients by giving them the right information at precisely the time of need. Its ultimate vision is a more transparent, knowledgeable and healthy world.

Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity.

LinkingMed Inc. focuses on building oncology data platform and medical data analysis. It offers AI and cloud based organ contouring, target delineation, automatic planning, radiotherapy quality assurance tools and services to radiotherapy department, third party medical imaging and radiotherapy centers. And it offers professional remote planning and radiotherapy network operation services to oncologists and medical physicists. LinkingMed Inc. keeps long-term and strategic collaboration with both international and domestic research and clinical institutes. It has applied more than ten national scientific funds and collaborated with NIH, Harvard Medical School, UT Southwestern Medical Center.

OBMedical was a digital health company with an FDA cleared fetal monitoring system now on the market for hospital use. The company launched a wearable fetal monitor and contraction monitor in 2017 and was sold to Philips Healthcare in late 2018 OBMedical Company, a Delaware corporation, was a medical device company commercializing technology jointly developed by the University of Florida and Convergent Engineering, a biomedical engineering firm. The LaborView sensor system their initial product is a wireless, electrode-based, electronic maternal-fetal monitor sensor replacement system that measures labor contractions and the heart rates of both mother and child. The LaborView sensor system will replace current outdated sensors with more accurate, reliable, and comfortable sensors, enabling a safer and more cost-effective obstetric monitoring system with greater patient satisfaction. It is compatible with legacy electronic fetal monitors.

EPD Solutions (EPD), a member of the Hobart Group companies, is dedicated to improving the efficacy and efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias.

ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein. The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania.